Atlas Trials

LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer

Clinical trial NCT04762901 · WITHDRAWN

Trial details

NCT number
NCT04762901
Sponsor
Wake Forest University Health Sciences
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-04-01
Primary completion
2026-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.